Skip to main content
Explore URMC


Breast Cancer: MK-3475 as Adjuvant therapy for Triple Receptor-Negative Breast Cancer or Positive Lymph Nodes After Neoadjuvant Chemotherapy - S1418

Research Question:
Does the drug MK-3475 help the survival of patients with breast cancer?

Basic Study Information

The purpose of this study is to compare treated subjects' invasive disease-free survival of patients with triple-negative breast cancer after neoadjuvant chemotherapy.

Study Reference #: CBRS18089

Lead Researcher (Principal Investigator)

Lead Researcher: Alissa Huston

Study Contact Information

Study Coordinator: Kate Corcoran
Phone: (585) 275-7771

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search